Oxycodone-BSA Antigen

Manufactured by Antibodies.com and distributed through the AFMS catalogue, this Oxycodone-BSA conjugate is supplied as a ready-to-use liquid immunogen designed for immunoassay development targeting the opioid oxycodone. The reagent is presented as an Antigen-BSA conjugate in a 10 mM phosphate buffered saline formulation at pH 7.2, preserved with 0.01% sodium azide and shipped on cold packs to maintain stability from receipt through storage. Each vial contains 1 mg of material and is intended exclusively for research use, not for diagnostic procedures. The hapten-to-protein coupling ratio is approximately 22:1, providing consistent presentation of oxycodone epitopes on the carrier protein for antibody generation, screening, or assay calibration. Validated applications include ELISA and lateral flow (LF) immunoassays, and the conjugate pairs cleanly with the matching detection antibody HM343, supporting complete assay workflows for drugs-of-abuse testing panels. For short-term handling, the antigen should be kept at 2–8 °C for up to two weeks, while long-term storage is recommended at −20 °C with protection from repeated freeze-thaw cycles to preserve immunoreactivity. Researchers handling this product should be aware that it contains sodium azide as a preservative and must therefore be treated as a hazardous substance, requiring trained personnel and appropriate laboratory precautions during use and disposal.